BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8139546)

  • 1. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia.
    Wright DD; Sefton BM; Kamps MP
    Mol Cell Biol; 1994 Apr; 14(4):2429-37. PubMed ID: 8139546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the T-cell acute lymphoblastic leukemia-associated t(1;7)(p34;q34) that fuses LCK and TCRB.
    Burnett RC; Thirman MJ; Rowley JD; Diaz MO
    Blood; 1994 Aug; 84(4):1232-6. PubMed ID: 8049439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia.
    Tycko B; Smith SD; Sklar J
    J Exp Med; 1991 Oct; 174(4):867-73. PubMed ID: 1680958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
    Adler HT; Sefton BM
    Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unique amino-terminal domain of p56lck regulates interactions with tyrosine protein phosphatases in T lymphocytes.
    Gervais FG; Veillette A
    Mol Cell Biol; 1995 May; 15(5):2393-401. PubMed ID: 7739523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LCK gene is involved in the t(1;7)(p34;q34) in the T-cell acute lymphoblastic leukemia derived cell line, HSB-2.
    Burnett RC; David JC; Harden AM; Le Beau MM; Rowley JD; Diaz MO
    Genes Chromosomes Cancer; 1991 Nov; 3(6):461-7. PubMed ID: 1663780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site.
    Gervais FG; Chow LM; Lee JM; Branton PE; Veillette A
    Mol Cell Biol; 1993 Nov; 13(11):7112-21. PubMed ID: 8413300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions.
    Amrein KE; Panholzer B; Flint NA; Bannwarth W; Burn P
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10285-9. PubMed ID: 7694287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck.
    Raab M; Yamamoto M; Rudd CE
    Mol Cell Biol; 1994 May; 14(5):2862-70. PubMed ID: 7513045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394.
    Hardwick JS; Sefton BM
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4527-31. PubMed ID: 7538674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation.
    Zhao R; Yang FT; Alexander DR
    Cancer Cell; 2004 Jan; 5(1):37-49. PubMed ID: 14749125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase.
    Prasad KV; Kapeller R; Janssen O; Repke H; Duke-Cohan JS; Cantley LC; Rudd CE
    Mol Cell Biol; 1993 Dec; 13(12):7708-17. PubMed ID: 8246987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramolecular and extramolecular mechanisms repress the catalytic function of p56lck in resting T-lymphocytes.
    Weil R; Veillette A
    J Biol Chem; 1994 Sep; 269(36):22830-8. PubMed ID: 7521333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p56lck by p72syk through physical association and N-terminal tyrosine phosphorylation.
    Couture C; Baier G; Oetken C; Williams S; Telford D; Marie-Cardine A; Baier-Bitterlich G; Fischer S; Burn P; Altman A
    Mol Cell Biol; 1994 Aug; 14(8):5249-58. PubMed ID: 7518561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation.
    Veillette A; Fournel M
    Oncogene; 1990 Oct; 5(10):1455-62. PubMed ID: 2250907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein.
    Reedquist KA; Fukazawa T; Druker B; Panchamoorthy G; Shoelson SE; Band H
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4135-9. PubMed ID: 7514295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.
    Abraham N; Miceli MC; Parnes JR; Veillette A
    Nature; 1991 Mar; 350(6313):62-6. PubMed ID: 1706070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer investigations of p56-LCK function in IL-2-dependent T-cell lines: implications for mechanisms of IL-2-signal transduction.
    Taichman RS; Torigoe T; Tanaka S; Miyashita T; Reed JC
    Cytokine; 1992 Nov; 4(6):441-53. PubMed ID: 1292628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LckBP1, a proline-rich protein expressed in haematopoietic lineage cells, directly associates with the SH3 domain of protein tyrosine kinase p56lck.
    Takemoto Y; Furuta M; Li XK; Strong-Sparks WJ; Hashimoto Y
    EMBO J; 1995 Jul; 14(14):3403-14. PubMed ID: 7628441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.